Conflict of values in pharmaceutical research: Between public health and markets

Authors

  • Txetxu Ausín Instituto de Filosofía Centro de Ciencias Humanas y Sociales, CSIC

DOI:

https://doi.org/10.3989/arbor.2008.i730.182

Keywords:

Health, Forgotten Diseases, Drugs, Pharmaceutical research, Patents, Human Rights

Abstract


Million people live involved in the chronic circle of the disease and poverty and does not have access to the essential medicines that could alleviate or cure their diseases. The reason is double: the lack of research in diseases of the poorest (forgotten diseases) and the rigid system of pharmaceutical intellectual property (patents). Nevertheless, the right to primary health care and its corollary, the right to essential drugs, constitute the key of the fundamental and primary human right: the right to life. For that reason, the considerations of public health have to prioritize forehead to the logic of the market in the scope of the pharmaceutical investigation, looking for ways that promote the innovation and the companies’ viability along with the drug development and distribution for the greater number of patients.

Downloads

Download data is not yet available.

Author Biography

Txetxu Ausín, Instituto de Filosofía Centro de Ciencias Humanas y Sociales, CSIC

References

Ausín, T. (2007): “Tomando en serio los derechos de bienestar”, Enrahonar 40 (en prensa).

Check, E. (2006), “Medicina rebelde”, Foreign Policy Edición Española 16: 72-80.

De Currea-Lugo, V. (2005), La salud como derecho humano, Publicaciones de la Universidad de Deusto, Bilbao.

Farmer, P. (2005), Pathologies of Power. Health, Human Rights, and the New War on the Poor, University of California Press, Berkeley.

Gewirth, A. (1982): Human Rights, University of Chicago Press, Chicago.

Hong, E. [2004 (2006)], “El movimiento en favor de la atención primaria de la salud se enfrenta al libre mercado”, en M. Fort, M. A. Mercer y O. Gish (eds.), El negocio de la salud, Paidós, Barcelona, 73-96.

Jara, M. (2007): Traficantes de salud, Icaria, Barcelona.

Lanjouw, J. O. (2002): “A New Global Patent Regime for Diseases: US and Internacional Legal Issues”, Harvard Journal of Law & Technology 16(1), 1-40.

Lewis, M. (2006): “Receta para la corrupción”, Foreign Policy Edición Española, 16, 76-77.

Nussbaum, M. y Sen, A. (comps.), 1993, The Quality of Life, OUP, Oxford.

Pogge, T. (2002): World Poverty and Human Rights: Cosmopolitan Responsibilities and Reforms, Polity Press, Cambridge.

Puyol, A. y Rodríguez, H. (eds.) (2007): Bioética, justicia y globalización, Erein, Donostia.

Shapiro, J. (2007): “El arma más inteligente”, Foreign Policy Edición Española, 22, 78-79.

Zumla, A. (2004): “Reflexión y reacción: Medicamentos para enfermedades olvidadas”, Archipiélago, 64, 29-31.

Downloads

Published

2008-04-30

How to Cite

Ausín, T. (2008). Conflict of values in pharmaceutical research: Between public health and markets. Arbor, 184(730), 333–345. https://doi.org/10.3989/arbor.2008.i730.182

Issue

Section

Articles